News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Farzan Nima
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Farzan Nima (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 02/14/2023 |
4
| Farzan Nima (CEO) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 750,000 options to buy
@ $6.78, valued at
$5.1M
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Farzan Nima (CEO) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 400,000 options to buy
@ $10.03, valued at
$4M
|
|
| 06/03/2021 |
4
| Farzan Nima (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 8,293 options to buy
@ $51.48, valued at
$426.9k
|
|
| 02/16/2021 |
4
| Farzan Nima (CEO) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 275,000 options to buy
@ $35.38, valued at
$9.7M
|
|
| 05/29/2020 |
4
| Farzan Nima (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 8,500 options to buy
@ $28.74, valued at
$244.3k
|
|
|
|